Postprandial distress syndrome: stratification and management

References

• Tack J, Drossman DA. What’s new in Rome IV?.  Neurogastroenterol Motil. 2017;29:e13053.
   Google Scholar
• Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr;130(5):1466–1479.
   PubMed Web of Science ®Google Scholar
• Stanghellini V, Talley NJ, Chan F, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.
   PubMed Web of Science ®Google Scholar
• Tack J, Talley NJ. Functional dyspepsia-symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol. 2013;10:134–141.
   PubMed Web of Science ®Google Scholar
• Carbone F, Holvoet L, Tack J. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap. Neurogastroenterol Motil. 2015 Aug;27(8):1069–1074.
   PubMed Web of Science ®Google Scholar
• Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252–262. Epub 2018 Feb 1.
   PubMed Web of Science ®Google Scholar
• Carbone F, Vandenberghe A, Holvoet L, et al. The impact of Rome IV criteria on functional dyspepsia subgroups in secondary care (abstract). Gastroenterology. 2017;152(5):S304.
   PubMed Web of Science ®Google Scholar
• Matsuzaki J, Suzuki H, Asakura K, et al. Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol Motil. 2012 Apr;24(4):325–e164.
   PubMed Web of Science ®Google Scholar
• Piessevaux H, de Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009 Apr;21(4):378–388.
   PubMed Web of Science ®Google Scholar
• Aziz I, Palsson OS, Törnblom H, et al. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018 Jan;113(1):86–96.
   PubMed Web of Science ®Google Scholar
• Brook RA, Kleinman NL, Choung RS, et al. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun;8(6):498–503.
   PubMed Web of Science ®Google Scholar
• Tack J, Caenepeel P, Arts J, et al. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005 Oct;54(10):1370–1376.
   PubMed Web of Science ®Google Scholar
• Quigley EM, Lacy BE. Overlap of functional dyspepsia and GERD–diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):175–186.
   PubMed Web of Science ®Google Scholar
• Xiao YL, Peng S, Tao J, et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am J Gastroenterol. 2010 Dec;105(12):2626–2631.
   PubMed Web of Science ®Google Scholar
• Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology. 2016 Feb 15;pii:S0016-5085(16)00178–5.
   Google Scholar
• Park JM, Choi MG, Cho YK, et al. Functional gastrointestinal disorders diagnosed by Rome III questionnaire in Korea. J Neurogastroenterol Motil. 2011 Jul;17(3):279–286.
   PubMed Web of Science ®Google Scholar
• Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988–1013. Epub 2017 Jun 20.
   PubMed Web of Science ®Google Scholar
• Enck P, Azpiroz F, Boeckxstaens G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017 Nov;3(3):17081.
   PubMedGoogle Scholar
• Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III criteria. Am J Gastroenterol. 2017 Jan;112(1):132–140.
   PubMed Web of Science ®Google Scholar
• Karamanolis G, Caenepeel P, Arts J, et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate of proximal stomach dysfunction. Gut. 2007 Jan;56(1):29–36.
   PubMed Web of Science ®Google Scholar
• Janssen P, Harris MS, Jones M, et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol. 2013 Sep;108(9):1382–1391.
   PubMed Web of Science ®Google Scholar
• Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346–1352.
   PubMed Web of Science ®Google Scholar
• Piessevaux H, Tack J, Walrand S, et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil. 2003;15:447–455.
   PubMed Web of Science ®Google Scholar
• Kuiken SD, Samsom M, Camilleri M, et al. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999 Dec;277(6 Pt 1):G1217–21.
   PubMedGoogle Scholar
• Janssen P, Verschueren S, Giao Ly H, et al. Intragastric pressure during food intake: a physiological and minimally invasive method to assess gastric accommodation. Neurogastroenterol Motil. 2011;23(4):316–22, e153-4.
   Web of Science ®Google Scholar
• Tack J, Caenepeel P, Piessevaux H, et al. Assessment of meal-induced gastric accommodation by a satiety drinking test in health and in functional dyspepsia. Gut. 2003;52:1271–1277.
   PubMed Web of Science ®Google Scholar
• Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with delayed emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783–788.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May;96(5):1422–1428.
   PubMed Web of Science ®Google Scholar
• Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014 Dec;63(12):1972–1978.
   PubMed Web of Science ®Google Scholar
• Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004 Dec;127(6):1685–1694.
   PubMed Web of Science ®Google Scholar
• Park SY, Acosta A, Camilleri M, et al. Gastric motor dysfunction in patients with functional gastroduodenal symptoms. Am J Gastroenterol. 2017 Nov;112(11):1689–1699.
   PubMed Web of Science ®Google Scholar
• Simrén M, Törnblom H, Palsson OS, et al. Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut. 2018 Feb;67(2):255–262.
   PubMed Web of Science ®Google Scholar
• Hammer J, Führer M. Clinical characteristics of functional dyspepsia depending on chemosensitivity to capsaicin. Neurogastroenterol Motil. 2017 Oct;29(10):1–12.
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Demyttenaere K, Tack J, et al. Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):663–680.
   PubMed Web of Science ®Google Scholar
• Jones MP, Tack J, Van Oudenhove L, et al. Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1014–1020.
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Vandenberghe J, Vos R, et al. Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med. 2011 Oct;73(8):648–655.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang R, Hou B, et al. Regional brain activity during rest and gastric water load in subtypes of functional dyspepsia: a preliminary brain functional magnetic resonance imaging study. J Neurogastroenterol Motil. 2018;24:268–279.
   PubMed Web of Science ®Google Scholar
• Mak ADP, Northoff G, Yeund DKW, et al. Increased glutamate in somatosensory cortex in functional dyspepsia. Scientific Reports. 2017;7:3926.
   PubMed Web of Science ®Google Scholar
• Ly HG, Ceccarini J, Weltens N, et al. Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study. Psychother Psychosom. 2015;84(3):149–158.
   PubMed Web of Science ®Google Scholar
• Ameloot K, Janssen P, Scarpellini E, et al. Endocannabinoid control of gastric sensorimotor function in man. Aliment Pharmacol Ther. 2010 May;31(10):1123–1131.
   PubMed Web of Science ®Google Scholar
• Moreira FA, Grieb M, Lutz B. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):133–144.
   PubMed Web of Science ®Google Scholar
• Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014 Feb;63(2):262–271.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1175–1183.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al., faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 64:1353–1367.
   PubMed Web of Science ®Google Scholar
• Igarashi M, Nakae H, Matsuoka T, et al. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastro. 2017;3:e000144.
   Google Scholar
• Zhong L, Shanahan ER, Raj A, et al. Dyspepsia and the microbiome: time to focus on the small intestine. Gut. 2017 Jun;66(6):1168–1169.
   PubMed Web of Science ®Google Scholar
• Carbone F, Vandenberghe A, Holvoet L, et al. Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome. Aliment Pharmacol Ther. 2016 Nov;44(9):989–1001.
   PubMed Web of Science ®Google Scholar
• Bisschops R, Karamanolis G, Arts J, et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut. 2008 Nov;57(11):1495–1503.
   PubMed Web of Science ®Google Scholar
• Feinle-Bisset C, Azpiroz F. Dietary and lifestyle factors in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):150–157.
   PubMed Web of Science ®Google Scholar
• Xu S, Wan X, Zheng X, et al. Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study. Int J Clin Exp Med. 2013 Sep 25;6(9):747–756.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Delaney BC, Vakil N, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004 Nov;127(5):1329–1337.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kusunoki H, Kamiya T, et al. Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): a multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial. United European Gastroenterol J. 2013 Dec;1(6):445–452.
   PubMed Web of Science ®Google Scholar
• Hsu Y-C, Liou J-M, Yang T-H, et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is a therapeutic response predicted by Rome III subgroups? J Gastroenterol. 2011;46:183–190.
   PubMed Web of Science ®Google Scholar
• Tack J. Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol. 2008 Dec;8(6):690–696.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Piessevaux H, Yiannakou Y, et al. Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials. Dig Dis Sci. 2016 Aug;61(8):2357–2372.
   PubMed Web of Science ®Google Scholar
• Carbone F, Rotondo A, Andrews CN, et al. A controlled cross-over trial shows benefit of prucalopride for symptom control and gastric emptying enhancement in idiopathic gastroparesis. Gastroenterology. 2016;150(4):S213- S214.
   Web of Science ®Google Scholar
• Levinthal DJ, Bielefeldt K. Systematic review and meta-analysis: gastric electrical stimulation for gastroparesis. Auton Neurosci. 2017 Jan;202:45–55.
   PubMed Web of Science ®Google Scholar
• Wo JM, Nowak TV, Waseem S, et al. Gastric electrical stimulation for gastroparesis and chronic unexplained nausea and vomiting. Curr Treat Options Gastroenterol. 2016 Dec;14(4):386–400.
   PubMedGoogle Scholar
• Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012 Nov;10(11):1239–1245.
   PubMed Web of Science ®Google Scholar
• Miwa H, Nagahara A, Tominaga K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009 Nov;104(11):2779–2787.
   PubMed Web of Science ®Google Scholar
• Altan E, Masaoka T, Farré R, et al. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol. 2012 Sep;6(5):533–544.
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Haruma K, Manabe N, et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012 Jun;24(6):540–5, e250-1.
   PubMed Web of Science ®Google Scholar
• Matsueda K, Hongo M, Tack J, et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012 Jun;61(6):821–828.
   PubMed Web of Science ®Google Scholar
• Tack J, Pokrotnieks J, Urbonas G, et al. Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial. Neurogastroenterol Motil. 2018 Jun;30(6):e13284.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Locke GR, Saito YA, et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015 Aug;149(2):340–9.e2.
   PubMed Web of Science ®Google Scholar
• Ford AC, Luthra P, Tack J, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66(3):411–420.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Tack J, Ford AC, et al. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology. 2018 Mar;154(4):1140–1171.e1.
   PubMed Web of Science ®Google Scholar
• Tack J, Ly HG, Carbone F, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016 Mar;14(3):385–392.e4.
   PubMed Web of Science ®Google Scholar
• Carbone F, Vanuytsel T, Tack J. The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects. Neurogastroenterol Motil. 2017 Dec;29(12).
   Web of Science ®Google Scholar
• Suzuki H, Inadomi JM, Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil. 2009 Jul;21(7):688–696.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P. STW 5 (Iberogast) therapy in gastrointestinal functional disorders. Dig Dis. 2017;35(Suppl 1):25–29.
   PubMedGoogle Scholar
• Suzuki H, Matsuzaki J, Fukushima Y, et al. Rikkunshito study group. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia–a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil. 2014 Jul;26(7):950–961.
   PubMed Web of Science ®Google Scholar
• Togawa K, Matsuzaki J, Kobayakawa M, et al. Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia. J Gastroenterol Hepatol. 2016 Feb;31(2):334–341.
   PubMed Web of Science ®Google Scholar
• Tominaga K, Sakata Y, Kusunoki H, et al. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study). Neurogastroenterol Motil. 2018 Mar 2. Epub ahead of print. DOI:10.1111/nmo.13319.
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Haruma K, Hata J, et al. Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med. 2010;49(20):2195–2202.
   PubMed Web of Science ®Google Scholar
• Rich G, Shah A, Koloski N, et al. A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil- preparation, on symptoms and quality of life in patients with functional dyspepsia. Neurogastroenterology & Motility. 2017;29:e13132.
   Google Scholar
• Papathanasopoulos A, Rotondo A, Janssen P, et al. Effect of acute peppermint oil administration on gastric sensorimotor function and nutrient tolerance in health. Neurogastroenterol Motil. 2013 Apr;25(4):e263–71.
   PubMed Web of Science ®Google Scholar
• Ohtsu T, Takag A, Uemura N, et al. The ameliorating effect of lactobacillus gasseri OLL2716 on functional dyspepsia in helicobacter pylori-uninfected individuals: a randomized controlled study. Digestion. 2017;96:92–102.
   PubMed Web of Science ®Google Scholar
• Tan VP, Liu KS, Lam FY, et al. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia. Aliment Pharmacol Ther. 2017 Mar;45(6):767–776.
   PubMed Web of Science ®Google Scholar
• Tack J, Corsetti M, Camilleri M, et al. Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts. Gut. 2018 Aug;67(8):1425–1433.
   PubMed Web of Science ®Google Scholar